
Sensif aims to enable fast, on-site diagnosis of joint infections by detecting multiple biomarkers in a single test. The system combines a paper-based electrochemical biosensor with artificial intelligence to interpret results. Core technologies include electrochemical biosensing on paper, AI data analysis, and multiplex biomarker detection. As a point-of-care device, it is designed for healthcare providers and research institutions across Europe, with a focus on cost-effectiveness and environmental friendliness. The project uses synovial fluid as the sample to diagnose periprosthetic joint infection and antimicrobial resistance.

Sensif aims to enable fast, on-site diagnosis of joint infections by detecting multiple biomarkers in a single test. The system combines a paper-based electrochemical biosensor with artificial intelligence to interpret results. Core technologies include electrochemical biosensing on paper, AI data analysis, and multiplex biomarker detection. As a point-of-care device, it is designed for healthcare providers and research institutions across Europe, with a focus on cost-effectiveness and environmental friendliness. The project uses synovial fluid as the sample to diagnose periprosthetic joint infection and antimicrobial resistance.